- Home
- IMCC vs IBIO Comparison
IMCC vs IBIO Comparison
Compare IMCC & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCC
- IBIO
- Stock Information
- Founded
- IMCC 1980
- IBIO 2008
- Country
- IMCC Israel
- IBIO United States
- Employees
- IMCC N/A
- IBIO N/A
- Industry
- IMCC Medicinal Chemicals and Botanical Products
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- IMCC Health Care
- IBIO Health Care
- Exchange
- IMCC Nasdaq
- IBIO Nasdaq
- Market Cap
- IMCC 11.8M
- IBIO 11.9M
- IPO Year
- IMCC N/A
- IBIO N/A
- Fundamental
- Price
- IMCC $2.56
- IBIO $0.77
- Analyst Decision
- IMCC
- IBIO Strong Buy
- Analyst Count
- IMCC 0
- IBIO 2
- Target Price
- IMCC N/A
- IBIO $5.50
- AVG Volume (30 Days)
- IMCC 50.5K
- IBIO 552.7K
- Earning Date
- IMCC 08-12-2025
- IBIO 09-19-2025
- Dividend Yield
- IMCC N/A
- IBIO N/A
- EPS Growth
- IMCC N/A
- IBIO N/A
- EPS
- IMCC N/A
- IBIO N/A
- Revenue
- IMCC $38,430,631.00
- IBIO $375,000.00
- Revenue This Year
- IMCC $47.12
- IBIO $81.33
- Revenue Next Year
- IMCC $12.83
- IBIO N/A
- P/E Ratio
- IMCC N/A
- IBIO N/A
- Revenue Growth
- IMCC 5.08
- IBIO 650.00
- 52 Week Low
- IMCC $1.29
- IBIO $0.56
- 52 Week High
- IMCC $7.12
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- IMCC 45.77
- IBIO 55.49
- Support Level
- IMCC $2.52
- IBIO $0.56
- Resistance Level
- IMCC $3.13
- IBIO $0.78
- Average True Range (ATR)
- IMCC 0.33
- IBIO 0.06
- MACD
- IMCC -0.00
- IBIO 0.01
- Stochastic Oscillator
- IMCC 29.87
- IBIO 72.48
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.